ReviewOncoTargets and therapy2023

Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers.

Alessandro Parisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.